Register entry
- Registered sites
- 2
- Active NDC listings
- 19
- Labeller names
- 4
- Live patents
- 0
- Countries
- 1
- Base
- France
Authorisation
Registered operations
Analytical testing2Active ingredient (API) manufacture2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| NOVACYL | RUE GASTON MONMOUSSEAU, ROUSSILLON, AUVERGNE RHONE ALPES 38150, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 3009804152263624659 |
| Novacyl | USINE DE SAINT FONS CHIMIE RUE PROSPER MONNET, Saint Fons, Rhone-Alpes 69190, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 3002807997383661402 |
Catalogue
Drug listings by form and route
1919 active NDC listings: 16 bulk ingredient, 3 drug for further processing. By marketing category: BULK INGREDIENT 16, DRUG FOR FURTHER PROCESSING 3.
| Dosage form | NDCs |
|---|---|
| powder | 10 |
| granule | 5 |
| crystal | 4 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| novacyl sas | 14 |
| novacyl | 3 |
| novacyl | 1 |
| novacyl sas | 1 |
Catalogue
Marketed products
19| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | ASPIRIN | crystal | 10357-205BULK INGREDIENT |
| - | ASPIRIN | crystal | 10357-209BULK INGREDIENT |
| - | ASPIRIN | granule | 10357-230DRUG FOR FURTHER PROCESSING |
| - | ASPIRIN | granule | 10357-235DRUG FOR FURTHER PROCESSING |
| - | ASPIRIN | granule | 10357-238DRUG FOR FURTHER PROCESSING |
| - | ASPIRIN | powder | 10357-240BULK INGREDIENT |
| - | ASPIRIN | crystal | 10357-306BULK INGREDIENT |
| - | ASPIRIN | crystal | 10357-309BULK INGREDIENT |
| - | ASPIRIN | granule | 10357-310BULK INGREDIENT |
| - | ASPIRIN | granule | 10357-313BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-320BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-323BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-701BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-702BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-705BULK INGREDIENT |
| - | ASPIRIN | powder | 10357-706BULK INGREDIENT |
| - | METHYL SALICYLATE | powder | 10357-700BULK INGREDIENT |
| - | SALICYLIC ACID | powder | 10357-788BULK INGREDIENT |
| - | SALICYLIC ACID | powder | 10357-790BULK INGREDIENT |
Compare
Comparable companies in France
- Guerbet LLC2 sites · 14 NDC
- Finorga2 sites · 9 NDC
- PMC Isochem2 sites · 6 NDC
- Biocodex2 sites · 4 NDC
- Albhades Provence2 sites · 0 NDC
- CEBIPHAR2 sites · 0 NDC
- CENEXI2 sites · 0 NDC
- Ceva Sante Animale2 sites · 0 NDC
- Eurofins Pharma Quality Control2 sites · 0 NDC
- Sevene SAS1 site · 154 NDC
Enquiry
Common questions
- Is Novacyl FDA approved?
- Novacyl holds 2 FDA-registered establishments in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Novacyl's drugs manufactured?
- The FDA register lists ROUSSILLON; Saint Fons. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does Novacyl make?
- 19 products are listed under Novacyl in the openFDA NDC Directory, most often as powder; granule; crystal. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.